Patent · US Active

Quinazoline derivatives

US9006255B2 · kind B2 · utility

2Cited by

0References

15Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventor

Markus Klein · Weiterstadt, DE

Key dates

Filing date	Sep 22, 2011
Grant date	Apr 14, 2015
Priority date	—
Expiry date	Nov 3, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula I in which R, X, L2 and A1-A6 have the meanings indicated in Claim 1, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.